Solid Biosciences
SLDB
$8.95
Share price
-3.76%
Change (1 day)
45.53%
Change (1 year)
Categories
Operating Margin for Solid Biosciences (SLDB)
Operating Margin as of May 2024 (TTM): -581.10%
According to Solid Biosciences 's latest financial reports and stock price the company's current Operating Margin is -581.10%. At the end of 2021 the company had an Operating Margin of -530.01%.
Operating Margin history for Solid Biosciences from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -530.01% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.